Baxter International Inc. and Carlyle have reached an agreement for Carlyle to acquire Baxter's Kidney Care segment for $3.8 billion. The deal is expected to close in late 2024 or early 2025. Baxter plans to use proceeds to reduce debt and focus on growth.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing